Julian C. Baker - 03 Jun 2025 Form 3 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Julian C. Baker
Issuer symbol
DNLI
Transactions as of
03 Jun 2025
Net transactions value
$0
Form type
3
Filing time
05 Jun 2025, 16:53:31 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BAKER JULIAN Director 860 WASHINGTON STREET, 3RD FLOOR, NEW YORK /s/ Julian C. Baker 05 Jun 2025 0001087939

No securities are beneficially owned.